Jerome Dvonch
Direttore Finanziario/CFO presso SONOMA PHARMACEUTICALS, INC.
Patrimonio netto: 2 481 $ in data 30/04/2024
Posizioni attive di Jerome Dvonch
Società | Posizione | Inizio | Fine |
---|---|---|---|
SONOMA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 08/09/2020 | - |
Storia della carriera di Jerome Dvonch
Precedenti posizioni note di Jerome Dvonch
Società | Posizione | Inizio | Fine |
---|---|---|---|
SONOMA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 08/09/2020 | 03/10/2022 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Direttore Finanziario/CFO | 01/07/2005 | 01/07/2015 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Corporate Officer/Principal | 01/06/2004 | 01/07/2005 |
EXELIXIS, INC. | Corporate Officer/Principal | 01/09/2000 | 01/06/2004 |
Spine Center Atlanta | Comptroller/Controller/Auditor | 01/03/2017 | - |
PHARMCHEM, INC. | Corporate Officer/Principal | - | - |
NEOGENOMICS, INC. | Comptroller/Controller/Auditor | 01/08/2005 | - |
Direttore/Membro del Consiglio | 23/05/2011 | - | |
Direttore Finanziario/CFO | 05/04/2010 | 25/02/2011 |
Formazione di Jerome Dvonch
Rochester Christian University | Masters Business Admin |
Niagara University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Posizioni
Director of Finance/CFO | 4 |
Corporate Officer/Principal | 3 |
Comptroller/Controller/Auditor | 2 |
Settori
Health Technology | 4 |
Health Services | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
PHARMCHEM, INC. | Health Services |
NEOGENOMICS, INC. | Health Services |
EXELIXIS, INC. | Health Technology |
SONOMA PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Health Services |
Spine Center Atlanta |
- Borsa valori
- Insiders
- Jerome Dvonch
- Esperienza